Ferring moves to acquire Gameto in $1.38b deal
Swiss fertility heavyweight bets on stem-cell-derived egg maturation – and on ovarian biology as a market worth owning. Fifty-odd years into the business of helping people build families, Ferring would now like to own some of the cells as well. The Swiss pharmaceutical group has signed an agreement
<p>Swiss fertility heavyweight bets on stem-cell-derived egg maturation – and on ovarian biology as a market worth owning. Fifty-odd years into the business of helping people build families, Ferring would now like to own some of the cells as well. The Swiss pharmaceutical group has signed an agreement </p>